Quote | Opthea Limited (NASDAQ:OPT)
Last: | $1.89 |
---|---|
Change Percent: | -0.31% |
Open: | $1.8958 |
Close: | $1.89 |
High: | $1.93 |
Low: | $1.89 |
Volume: | 7,214 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Opthea Limited (NASDAQ:OPT)
Fully underwritten Retail Entitlement Offer to open at 9:00 am (Melbourne time) on 19 June 2024 Retail Entitlement Offer to raise approximately A$55.0m (US$36.9m 1 ) will close at 5:00 pm (Melbourne time) on 10 July 2024 Prospectus and personalized application ...
Fully underwritten Retail Entitlement Offer to raise a further approximately A$55.9m (US$36.9m 1 ) will open on 19 June 2024 and close at 5:00 pm (Melbourne time) on 10 July 2024 MELBOURNE, Australia and PRINCETON, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ...
Message Board Posts | Opthea Limited (NASDAQ:OPT)
Subject | By | Source | When |
---|---|---|---|
$OPT: Sudden popping to $14.............. | makinezmoney | investorshub | 06/16/2021 2:41:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Fully underwritten Retail Entitlement Offer to open at 9:00 am (Melbourne time) on 19 June 2024 Retail Entitlement Offer to raise approximately A$55.0m (US$36.9m 1 ) will close at 5:00 pm (Melbourne time) on 10 July 2024 Prospectus and personalized application ...
Fully underwritten Retail Entitlement Offer to raise a further approximately A$55.9m (US$36.9m 1 ) will open on 19 June 2024 and close at 5:00 pm (Melbourne time) on 10 July 2024 MELBOURNE, Australia and PRINCETON, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ...
Financing extends Opthea’s cash runway through Phase 3 topline data readout for both pivotal trials of sozinibercept in wet AMD Phase 3 topline data readout accelerated for COAST to early Q2 calendar year 2025, and anticipated for ShORe in mid-calendar year 2025 MELBOURNE, Au...